(Q38215595)

31 August 2017

title

Applications of TALENs and CRISPR/Cas9 in human cells and their potentials for gene therapy (English)

1 reference

31 August 2017

0 references

0 references

0 references

Jingwen Niu

1

1 reference

31 August 2017

Bin Zhang

series ordinal

2

1 reference

31 August 2017

Hu Chen

series ordinal

3

1 reference

31 August 2017

publication date

1 August 2014

1 reference

31 August 2017

published in

Molecular Biotechnology

1 reference

31 August 2017

volume

56

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

681-688

1 reference

Gene therapy: twenty-first century medicine

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

A TALEN genome-editing system for generating human stem cell-based disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Targeting DNA double-strand breaks with TAL effector nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

A TALE nuclease architecture for efficient genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Genetic engineering of human pluripotent cells using TALE nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

TAL effectors: customizable proteins for DNA targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Breaking the code of DNA binding specificity of TAL-type III effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

TAL effectors: finding plant genes for disease and defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

A simple cipher governs DNA recognition by TAL effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

CRISPR/Cas, the immune system of bacteria and archaea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Efficient genome editing in zebrafish using a CRISPR-Cas system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

RNA-guided editing of bacterial genomes using CRISPR-Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Gene knockout using transcription activator-like effector nucleases (TALENs) reveals that human NDUFA9 protein is essential for stabilizing the junction between membrane and matrix arms of complex I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

RNA-programmed genome editing in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Multiplex genome engineering using CRISPR/Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

A library of TAL effector nucleases spanning the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

TALEN or Cas9 - rapid, efficient and specific choices for genome modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Optimization of scarless human stem cell genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Genetic screens in human cells using the CRISPR-Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Precision genome engineering with programmable DNA-nicking enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

DNA targeting specificity of RNA-guided Cas9 nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Genome engineering using the CRISPR-Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Generation of a nicking enzyme that stimulates site-specific gene conversion from the I-AniI LAGLIDADG homing endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Biological and biomedical applications of engineered nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

TALEN-based gene correction for epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Efficient TALEN construction and evaluation methods for human cell and animal applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Genome-scale CRISPR-Cas9 knockout screening in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-014-9771-Z

Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24870618

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

TAL effector RVD specificities and efficiencies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24870618

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12033-014-9771-Z

1 reference

31 August 2017

1 reference